The investigation of the involvement of DAG-regulated signalling pathways in SCRIBRNAi/H-RASG12V tumour growth and the effect of inhibition of DGKα on these pathways will be important in providing a full picture of the involvement of DGKα in Ras-driven cancers. The gene discussed is DGKA; the disease is cancer.